Document is current

Any future updates will be listed below

Correction to: ERCC6L that is up-regulated in high grade of renal cell carcinoma enhances cell viability in vitro and promotes tumor growth in vivo potentially through modulating MAPK signalling pathway

Crossref DOI link: https://doi.org/10.1038/s41417-021-00417-2

Published Online: 2022-01-28

Published Print: 2022-08

Update policy: https://doi.org/10.1007/springer_crossmark_policy

About CrossMark